Journal for ImmunoTherapy of Cancer (Nov 2021)

895 Discovery of a safer 4–1BB agonist by targeting a membrane-proximal epitope combined with bispecific-mediated cross-bridging

  • Bin Li,
  • Tao Wang,
  • Yuhua Huang,
  • Yifeng Xu,
  • Chao Wang,
  • Tianhang Zhai,
  • Weifeng Huang,
  • Zhijun Yuan,
  • Shuang Dai,
  • Shaogang Peng,
  • Tuling Pang,
  • Wenchao Jiang,
  • Yuefeng Zou,
  • Yingda Xu,
  • Joanne Sun,
  • Xinjiang Gong,
  • Andy Tsun,
  • Xiaoniu Miao

DOI
https://doi.org/10.1136/jitc-2021-SITC2021.895
Journal volume & issue
Vol. 9, no. Suppl 2

Abstract

Read online

No abstracts available.